Report #2829490

Overview

Sex

Female

Age

Age unknown

State

NH

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

The patient only took three out of four doses of Vivotif before the medication was lost; Case reference number US-BN-2024-000644 is a spontaneous case report initially received from a pharmacist via Med Communications (reference number: USBAV24-0532) on 18-Mar-2024 and concerns a female patient of unknown age. The patient's medical history and concomitant medication details were not provided. On unspecified dates, the patient took the first, second, and third dose of Vivotif (batch number: unknown), at an unknown dose or route of administration, for unknown indication. As reported, the patient only took three out of four doses before the medication was lost (explicitly coded as 'missed dose'). The patient wanted to know if the vaccination needed to be restarted. At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. No further information was provided.; Reporter's Comments: A female patient of unknown age took the first, second, and third dose of Vivotif for unknown indication. As reported, the patient only took three out of four doses before the medication was lost, which is considered as missed dose. It was unknown if the patient experienced any adverse event due to Vivotif. Product dose omission issue is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product dose omission issue has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unknown age took the first, second, and third dose of Vivotif for unknown indication. As reported, the patient only took three out of four doses before the medication was lost, which is considered as missed dose. It was unknown if the patient experienced any adverse event due to Vivotif. Product dose omission issue is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product dose omission issue has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.

Medical history

Comments: None